A Ph 4, Multicenter, Open-label Study to Evaluate Long-term Safety and Efficacy of Revakinagene Taroretcel-Lwey (NT-501) Previously Implanted in a Ph 1, Ph 2, or Ph 3 Clinical Study and to Evaluate NT-501 Implanted in Participants...